Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
16
pubmed:dateCreated
1996-9-12
pubmed:databankReference
pubmed:abstractText
Aldose reductase (EC 1.1.1.21) catalyzes the NADPH-mediated conversion of glucose to sorbitol. The hyperglycemia of diabetes increases sorbitol production primarily through substrate availability and is thought to contribute to the pathogenesis of many diabetic complications. Increased sorbitol production can also occur at normoglycemic levels via rapid increases in aldose reductase transcription and expression, which have been shown to occur upon exposure of many cell types to hyperosmotic conditions. The induction of aldose reductase transcription and the accumulation of sorbitol, an organic osmolyte, have been shown to be part of the physiological osmoregulatory mechanism whereby renal tubular cells adjust to the intraluminal hyperosmolality during urinary concentration. Previously, to explore the mechanism regulating aldose reductase levels, we partially characterized the human aldose reductase gene promoter present in a 4.2-kb fragment upstream of the transcription initiation start site. A fragment (-192 to +31 bp) was shown to contain several elements that control the basal expression of the enzyme. In this study, we examined the entire 4.2-kb human AR gene promoter fragment by deletion mutagenesis and transfection studies for the presence of osmotic response enhancer elements. An 11-bp nucleotide sequence (TGGAAAATTAC) was located 3.7 kb upstream of the transcription initiation site that mediates hypertonicity-responsive enhancer activity. This osmotic response element (ORE) increased the expression of the chloramphenicol acetyltransferase reporter gene product 2-fold in transfected HepG2 cells exposed to hypertonic NaCl media as compared with isoosmotic media. A more distal homologous sequence is also described; however, this sequence has no osmotic enhancer activity in transfected cells. Specific ORE mutant constructs, gel shift, and DNA fragment competition studies confirm the nature of the element and identify specific nucleotides essential for enhancer activity. A plasmid construct containing three repeat OREs and a heterologous promoter increased expression 8-fold in isoosmotic media and an additional 4-fold when the transfected cells are subjected to hyperosmotic stress (total approximately 30-fold). These findings will permit future studies to identify the transcription factors involved in the normal regulatory response mechanism to hypertonicity and to identify whether and how this response is altered in a variety of pathologic states, including diabetes.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8710921-1370453, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710921-1372904, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710921-1401064, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710921-1518851, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710921-1628753, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710921-1748296, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710921-1901857, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710921-1924548, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710921-2493741, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710921-2506183, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710921-2514350, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710921-3035099, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710921-3080763, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710921-3104902, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710921-3821727, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710921-4266466, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710921-6276559, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710921-6305407, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710921-6814912, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710921-6888276, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710921-6960240, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710921-7862636, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710921-7938022, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710921-7961914, http://linkedlifedata.com/resource/pubmed/commentcorrection/8710921-8340427
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
6
pubmed:volume
93
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
8624-9
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
Characterization of the osmotic response element of the human aldose reductase gene promoter.
pubmed:affiliation
Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.